Related Experiment Videos
Two human colon tumor cell lines with similar nuclease sensitivities have different ethidium bromide binding
Abstract:
Chromatin from two human colon adenocarcinoma cell lines (HT-29 and LoVo) showed similar digestion kinetics when sensitivities to DNase I and micrococcal nuclease were examined. Chromatin conformations were probed by examining the binding of ethidium bromide. A Scatchard plot revealed that both chromatins bound the same amount of ethidium bromide per mole of DNA, but the DNA from LoVo cells was more accessible to the intercalator. The results indicate that differences in chromatin conformation are not necessarily accompanied by different nuclease sensitivities.
Insights
Chromatin from colon cancer cells (HT-29 and LoVo) digested similarly with nucleases. However, LoVo cell DNA showed greater ethidium bromide accessibility, indicating distinct chromatin conformations despite similar nuclease sensitivities.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Chromatin structure influences DNA accessibility and gene regulation.
- Understanding chromatin conformation in cancer cells is crucial for therapeutic development.
Purpose of the Study:
- To compare chromatin structure and nuclease sensitivity in two human colon adenocarcinoma cell lines.
- To investigate the relationship between chromatin conformation and DNA accessibility.
Main Methods:
- Examined chromatin digestion kinetics using DNase I and micrococcal nuclease.
- Assessed chromatin conformation via ethidium bromide binding.
- Utilized Scatchard plot analysis to quantify DNA-protein interactions.
Main Results:
- Both HT-29 and LoVo cell chromatins exhibited similar digestion patterns with nucleases.
- Scatchard analysis indicated equivalent ethidium bromide binding capacity per DNA mole in both cell lines.
- DNA from LoVo cells demonstrated higher accessibility to ethidium bromide compared to HT-29 cells.
Conclusions:
- Differences in chromatin conformation do not always correlate with variations in nuclease sensitivity.
- Chromatin accessibility can differ between cancer cell lines even with similar nuclease digestion profiles.